NEXGEL
manufacturer: NEXTBIOMEDICAL CO., LTD.
Category: Treatment of endovascular embolization
- Effective embolization by highly cohesiveness and restoring force
- Anti-contamination vial design
- No-harmful chemical
Description
Indication:
| Transarterial chemoembolization for liver cancer. | Bleeding control |
 |  |
Pre-clinical Test Results
Histopathology results in rat liver
| Embolization | Few weeks after embolization |
 |  |
Result of angiography and CT scan of pig kidneys
| Pre-embolization | Embolization | Re-cannulation weeks after embolization |
 |  |  |
| Before embolization | 1 week after embolization | Few weeks after embolization | |
| Angiography F/U |  |  |  |
| CT scan F/U |  |  |  |
Specifications
| Ordering Code | Particle size | Quantity |
| NexGel 150 | 150-350 | 150 |
| NexGel 350 | 350-560 | 150 |
| NexGel 560 | 560-800 | 150 |
| NexGel 710 | 710-1100 | 150 |
| NexGel 1000 | 1000-1600 | 150 |
| NexGel 2000 | 2000-3500 | 150 |
